These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 13462210)

  • 1. [Modern trends in the treatment of cancer of the prostate: phosphorylated estrogens].
    CHIEREGO F; FABRIS P
    G Ital Chemioter; 1956; 3(3-4):569-71. PubMed ID: 13462210
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of prostate cancer with phosphorylated estrogens (estrol diphosphate)].
    CHIEREGO F; FABRIS P
    Arch Ital Urol; 1956; 29(5):357-83. PubMed ID: 13395753
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormono- therapy of cancer of the prostate].
    Albeaux-Fernet M; Bellot L; Canet L; Deribreux J; Gelinet M
    Annee Endocrinol; 1970; 22():181-91. PubMed ID: 5485068
    [No Abstract]   [Full Text] [Related]  

  • 4. Histological changes in carcinomatous prostate treated with phosphorylated estrogen.
    FABRIS P; CHIEREGO F
    Minerva Urol; 1957; 9(3):109-10. PubMed ID: 13493272
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of cancer of prostate & its metastases by chlorotrianisene (TACE)].
    HERBEUVAL R; GUILLEMIN P; CUNY G; LARCAN A; BESSOT M
    J Urol Medicale Chir; 1957 Jun; 63(6):422-6. PubMed ID: 13476487
    [No Abstract]   [Full Text] [Related]  

  • 6. [Remarks on hormonal treatment of prostatic canecer].
    Verrière P; Burlet P
    J Med Lyon; 1967 May; 48(121):869-70. PubMed ID: 5616975
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preliminary results obtained with hexestrol diphosphate in therapy of prostate cancer].
    COMAR OB; DELLI PAOLI A
    Riforma Med; 1957 Dec; 71(49):1395-9. PubMed ID: 13528575
    [No Abstract]   [Full Text] [Related]  

  • 8. TACE in the treatment of carcinoma of the prostate: an 80-month surgery.
    CARROLL G; BRENNAN RV
    Trans South Cent Sect Am Urol Assoc; 1957; 52():64-6. PubMed ID: 13556886
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with combined hormonal treatment of prostate carcinoma].
    PECHERSTORFER M
    Wien Med Wochenschr; 1959 Feb; 109(6):133-4. PubMed ID: 13648373
    [No Abstract]   [Full Text] [Related]  

  • 10. [Estrogen therapy of prostate cancer].
    OBERHOLTZER A
    Minerva Urol; 1956; 8(4):127-35. PubMed ID: 13369344
    [No Abstract]   [Full Text] [Related]  

  • 11. [New treatments for cancer of the prostate].
    AMIEL C
    Vie Med; 1959 Apr; 40(4):337 passim. PubMed ID: 13659813
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy of prostate carcinoma].
    MULLER F
    Rozhl Chir; 1958 Feb; 35(1):53-7. PubMed ID: 13467023
    [No Abstract]   [Full Text] [Related]  

  • 13. [New advances in hormonal treatment of prostate cancer; the use of chlorotrianisene].
    RAVINA A
    Presse Med (1893); 1955 Sep; 63(59):1198. PubMed ID: 13266742
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of estrogens in development of prostate cancer.
    Härkönen PL; Mäkelä SI
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):297-305. PubMed ID: 15663993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mammary carcinoma after stilbene treatment of a prostate carcinoma].
    KELLER J
    Z Arztl Fortbild (Jena); 1953 Aug; 47(16):584-6. PubMed ID: 13103170
    [No Abstract]   [Full Text] [Related]  

  • 16. [The treatment of prostate carcinoma with depot-dienol forte].
    BUCHER A
    Wien Med Wochenschr; 1955 Dec; 105(48):1006-7. PubMed ID: 13300049
    [No Abstract]   [Full Text] [Related]  

  • 17. TACE in prostatic cancer: clinical and biochemical considerations.
    CARROLL G; BRENNAN RV
    J Urol; 1954 Sep; 72(3):497-503. PubMed ID: 13202238
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recurrent lung metastases in prostate carcinoma and Cyren A implantation].
    LANGE
    Z Urol; 1953; 46(5):333-6. PubMed ID: 13103625
    [No Abstract]   [Full Text] [Related]  

  • 19. TACE in the endocrine management of prostatic carcinoma.
    HEADSTREAM JW; ALLEN DO; JONES BW
    J Am Geriatr Soc; 1957 Apr; 5(4):453-5. PubMed ID: 13428532
    [No Abstract]   [Full Text] [Related]  

  • 20. TACE in the treatment of carcinoma of the prostate: an 80-month survey.
    CARROLL G; BRENNAN RV
    J Urol; 1958 Aug; 80(2):155-7. PubMed ID: 13564606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.